La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Westlake Chemical a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Westlake Chemical..

Westlake Chemical (NYSE:WLKP) Azioni, Catena delle Opzioni

Westlake Chemical

Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develop ethyelene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.

Westlake Chemical Partners LP Common Units representing limited partner interests

Westlake Chemical Partners LP

Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.36 by 41.67 percent. The company reported quarterly sales of $276.995 million which beat the analyst consensus estimate of $244.000 million by 13.52 percent. This is a 13.89 percent decrease over sales of $321.664 million the same period last year.

Earnings

Earnings Beats

News

WLKP

Westlake Chemical Q3 2024 GAAP EPS $0.51 Beats $0.36 Estimate, Sales $276.995M Beat $244.000M Estimate

Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) will release its quarterly earnings report on Tuesday, 2024-11-05. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Westlake Chemical to report an earnings per share (EPS) of $0.37.
The announcement from Westlake Chemical is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Performance in Previous Earnings</h3>
Last quarter the company missed EPS by $0.02, which was followed by a 1.35% drop in the share price the next day.
Here's a look at Westlake Chemical's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.43</td>
<td>0.45</td>
<td>0.45</td>
<td>0.44</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.41</td>
<td>0.42</td>
<td>0.41</td>
<td>0.37</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.0%</td>
<td>2.0%</td>
<td>0.0%</td>
<td>-3.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1730743353_0.png" alt="eps graph" />
<h3>Tracking Westlake Chemical's Stock Performance</h3>
Shares of Westlake Chemical were trading at $22.35 as of November 01. Over the last 52-week period, shares are up 2.82%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/WLKP/earnings">To track all earnings releases for Westlake Chemical visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For Westlake Chemical

In the current market session, Westlake Chemical Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) stock price is at $22.45, after a 0.04% drop. However, over the past month, the company's stock increased by 0.27%, and in the past year, by 4.76%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2024/1730122417_0.png" alt="Past Year Chart" />

<h3>Westlake Chemical P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 145.18 in the Chemicals industry, Westlake Chemical Inc. has a lower P/E ratio of 13.95. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1730122417_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

A Look Into Westlake Chemical Inc's Price Over Earnings

U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Monday.
Shares of PDD Holdings Inc &#8211; ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) fell sharply in today's pre-market trading after the company reported <a href="https://www.benzinga.com/news/earnings/24/08/40548945/temu-parent-pdd-posts-86-q2-topline-growth-stock-drops-after-ceo-flags-upcoming-challenges">second-quarter revenue miss.</a>
PDD reported fiscal second-quarter 2024 revenue growth of 86% year-on-year to $13.36 billion (97.06 billion Chinese yuan), missing the analyst consensus estimate of $14.02 billion. The Chinese online retailer's adjusted earnings per ADS of $3.20 (23.24 Chinese yuan) increased from 10.47 Chinese yuan Y/Y, beating the analyst consensus estimate of $2.73.
PDD shares dipped 15.2% to $118.65 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>SM Energy Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SM#NYSE">SM</a>) fell 7.5% to $42.42 in pre-market trading after gaining over 3% on Friday.</li>
<li>Westlake Chemical Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) shares dipped 5.4% to $21.50 in pre-market trading.</li>
<li>AngioDynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) shares fell 5.1% to $7.29 in pre-market trading.</li>
<li>Daqo New Energy Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DQ#NYSE">DQ</a>) shares declined 5.1% to $14.43 in pre-market trading after reporting downbeat quarterly results.</li>
<li>Yiren Digital Ltd &#8211; ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YRD#NYSE">YRD</a>) shares fell 4.6% to $4.63 in pre-market trading.</li>
<li>elf Beauty Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) shares declined 3.8% to $164.50 in pre-market trading.</li>
<li>Guardant Health Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GH#NASDAQ">GH</a>) shares fell 3% to $28.20 in pre-market trading after gaining 4% on Friday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/08/40547904/pvh-likely-to-report-higher-q2-earnings-these-most-accurate-analysts-revise-forecasts-ahead-of-earn">PVH Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>

Pre-Market Outlook

Movers

Trading Ideas

ANGO

Citigourp Global Markets 2% Protected Notes Linked To The Djia

PDD Holdings, Daqo New Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session

A notable insider purchase on August 14, was reported by Andrew Kenner, SVP at Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>), based on the most recent SEC filing.
What Happened: In a recent Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001604665/000095017024096710//Archives/edgar/data/1604665/000095017024096710/0000950170-24-096710-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday, Kenner increased their investment in Westlake Chemical by purchasing 2,692 shares through open-market transactions, signaling confidence in the company's potential. The total transaction value is $60,914.
Westlake Chemical's shares are actively trading at $22.33, experiencing a down of 0.58% during Wednesday's morning session.
<h3>All You Need to Know About Westlake Chemical</h3>
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develop ethyelene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
<h3>Westlake Chemical: Financial Performance Dissected</h3>
Positive Revenue Trend: Examining Westlake Chemical's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 7.57% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Materials sector.
Insights into Profitability:
<ul>
<li>
Gross Margin: The company excels with a remarkable gross margin of 35.62%, indicating superior cost efficiency and profitability compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): With an EPS below industry norms, Westlake Chemical exhibits below-average bottom-line performance with a current EPS of 0.41.
</li>
</ul>
Debt Management: Westlake Chemical's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.45, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Insights into Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: Westlake Chemical's P/E ratio of 13.95 is below the industry average, suggesting the stock may be undervalued.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 0.67, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio 2.32 is below the industry average, indicating that it may be relatively undervalued compared to peers.
</li>
</ul>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Unmasking the Significance of Insider Transactions</h3>
Considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Deciphering Transaction Codes in Insider Filings</h3>
Delving into transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> typically prioritize those unfolding in the open market, as precisely outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001604665">Check Out The Full List Of Westlake Chemical's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Smart Money Move: Andrew Kenner Grabs $60K Worth Of Westlake Chemical Stock

Disclosed in the latest SEC filing, a significant insider purchase on August 12, involves Andrew Kenner, SVP at Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>).
What Happened: In a significant move reported in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001604665/000095017024095112//Archives/edgar/data/1604665/000095017024095112/0000950170-24-095112-index.htm">U.S. Securities and Exchange Commission</a> on Monday, Kenner purchased 12,000 shares of Westlake Chemical, demonstrating confidence in the company's growth potential. The total value of the transaction stands at $275,868.
Westlake Chemical's shares are actively trading at $22.61, experiencing a up of 0.62% during Monday's morning session.
<h3>Discovering Westlake Chemical: A Closer Look</h3>
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develop ethyelene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
<h3>Financial Milestones: Westlake Chemical's Journey</h3>
Revenue Challenges: Westlake Chemical's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -0.18%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Navigating Financial Profits:
<ul>
<li>
Gross Margin: The company maintains a high gross margin of 35.62%, indicating strong cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Westlake Chemical's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.41.
</li>
</ul>
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.45, caution is advised due to increased financial risk.
Insights into Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: The P/E ratio of 14.25 is lower than the industry average, implying a discounted valuation for Westlake Chemical's stock.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 0.68, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With a below-average EV/EBITDA ratio of 2.35, Westlake Chemical presents an opportunity for value investors. This lower valuation may attract investors seeking undervalued opportunities.
</li>
</ul>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Delving Into the Significance of Insider Transactions</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Navigating the World of Insider Transaction Codes</h3>
When dissecting transactions, the focal point for <a href="https://www.benzinga.com/money/investing-tools">investors</a> is often those occurring in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001604665">Check Out The Full List Of Westlake Chemical's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Eye On Growth: Andrew Kenner Adds $275K Of Westlake Chemical Stock To Portfolio

Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) reported quarterly earnings of $0.41 per share which missed the analyst consensus estimate of $0.44 by 6.82 percent. This is a 20.59 percent increase over earnings of $0.34 per share from the same period last year. The company reported quarterly sales of $284.168 million which beat the analyst consensus estimate of $270.000 million by 5.25 percent. This is a 7.57 percent increase over sales of $264.177 million the same period last year.

Earnings Misses

Westlake Chemical Q2 2024 GAAP EPS $0.41 Misses $0.44 Estimate, Sales $284.168M Beat $270.000M Estimate

Management

Westlake Chemical Partners Appoints Jean-Marc Gilson As Director, President, And CEO; Albert Chao Transitions To Executive Chairman, James Chao To Senior Chairman; Gilson Previously CEO Of Mitsubishi Chemical Group Corporation; Appointments Effective Today

In a recent SEC filing, it was revealed that Andrew Kenner, SVP at Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>), made a noteworthy insider purchase on May 14,.
What Happened: Kenner made a significant move by purchasing 7,178 shares of Westlake Chemical as reported in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001604665/000095017024059168//Archives/edgar/data/1604665/000095017024059168/0000950170-24-059168-index.htm">U.S. Securities and Exchange Commission</a>. The transaction's total worth stands at $158,439.
As of Tuesday morning, Westlake Chemical shares are down by 0.0%, currently priced at $22.19.
<h3>Unveiling the Story Behind Westlake Chemical</h3>
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develop ethyelene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
<h3>Key Indicators: Westlake Chemical's Financial Health</h3>
Revenue Growth: Westlake Chemical's revenue growth over a period of 3 months has faced challenges. As of 31 March, 2024, the company experienced a revenue decline of approximately -7.48%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Key Profitability Indicators:
<ul>
<li>
Gross Margin: The company excels with a remarkable gross margin of 35.89%, indicating superior cost efficiency and profitability compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Westlake Chemical's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.42.
</li>
</ul>
Debt Management: With a high debt-to-equity ratio of 1.44, Westlake Chemical faces challenges in effectively managing its debt levels, indicating potential financial strain.
Evaluating Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The P/E ratio of 14.41 is lower than the industry average, implying a discounted valuation for Westlake Chemical's stock.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 0.67 is below industry norms, suggesting potential undervaluation and presenting an investment opportunity for those considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Westlake Chemical's EV/EBITDA ratio, lower than industry averages at 2.39, indicates attractively priced shares.
</li>
</ul>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Navigating the Impact of Insider Transactions on Investments</h3>
It's important to note that insider transactions alone should not dictate investment decisions, but they can provide valuable insights.
Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
<h3>Navigating the World of Insider Transaction Codes</h3>
Digging into the details of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their attention to those taking place in the open market, as outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001604665">Check Out The Full List Of Westlake Chemical's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Westlake Chemical Recent Insider Activity

Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) reported quarterly earnings of $0.42 per share which missed the analyst consensus estimate of $0.43 by 2.33 percent. The company reported quarterly sales of $284.673 million which beat the analyst consensus estimate of $281.000 million by 1.31 percent. This is a 7.48 percent decrease over sales of $307.677 million the same period last year.

Westlake Chemical Q1 2024 GAAP EPS $0.42 Misses $0.43 Estimate, Sales $284.673M Beat $281.000M Estimate

Although U.S. stocks closed mostly lower on Monday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#39;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>Sow Good </h3>
<ul>
<li>The Trade: Sow Good Inc. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/sowg#OTC">SOWG</a>) Director Lyle Berman <a href="https://www.benzinga.com/quote/SOWG/analyst-ratings"> acquired a total of 68,966 shares </a> an average price of $7.25. To acquire these shares, it cost around $500,004.</li>
<li>What&rsquo;s Happening: On March 28, Sow Good announced a $3.7 million private placement.</li>
<li>What Sow Good Does: Sow Good Inc is engaged in manufacturing and marketing freeze-dried fruits, vegetables, snacks, smoothies, and soups.</li>
</ul>
<h3>Oncternal Therapeutics </h3>
<ul>
<li>The Trade: Oncternal Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/onct#NASDAQ">ONCT</a>) Director Robert James Wills acquired a total of 6,914 shares at an average price of $8.48. To acquire these shares, it cost around $58,602.</li>
<li>What&rsquo;s Happening: On March 7, Oncternal Therapeutics posted upbeat quarterly sales.</li>
<li>What Oncternal Therapeutics Does: Oncternal Therapeutics Inc is a clinical-stage oncology company developing first-in-class, novel therapies that target a broad spectrum of cancers with a large unmet medical need.</li>
</ul>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
<h3>Westlake Chemical Partners </h3>
<ul>
<li>The Trade: Westlake Chemical Partners LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wlkp#NYSE">WLKP</a>) SVP, Olefin Material &amp; Corp Pr Andrew Kenner <a href="https://www.benzinga.com/sec/insider-trades/"> bought a total of 5,000 shares </a> at an average price of $22.23. To acquire these shares, it cost around $111,150.</li>
<li>What&rsquo;s Happening: On Feb. 20, Westlake Chemical posted downbeat quarterly results.</li>
<li>What Westlake Chemical Partners Does: Westlake Chemical Partners LP is a part of the chemical industry in the United States.</li>
</ul>
&nbsp;
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/04/38038834/dave-busters-likely-to-report-higher-q4-earnings-here-are-the-recent-forecast-changes-from-wall-str"> Dave &amp; Buster&#39;s Likely To Report Higher Q4 Earnings; Here Are The Recent Forecast Changes From Wall Street&#39;s Most Accurate Analysts </a>

Long Ideas

Small Cap

ONCT

SOWG

Insiders Buying Westlake Chemical Partners And 2 Other Stocks

A significant insider buy by Andrew Kenner, SVP at Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>), was executed on April 1, and reported in the recent SEC filing.
What Happened: Kenner's recent move, as outlined in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001604665/000095017024038852//Archives/edgar/data/1604665/000095017024038852/0000950170-24-038852-index.htm">U.S. Securities and Exchange Commission</a> on Monday, involves purchasing 5,000 shares of Westlake Chemical. The total transaction value is $111,150.
The latest market snapshot at Monday morning reveals Westlake Chemical shares up by 1.35%, trading at $22.5.
<h3>Unveiling the Story Behind Westlake Chemical</h3>
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develop ethyelene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
<h3>Unraveling the Financial Story of Westlake Chemical</h3>
Decline in Revenue: Over the 3 months period, Westlake Chemical faced challenges, resulting in a decline of approximately -18.96% in revenue growth as of 31 December, 2023. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Navigating Financial Profits:
<ul>
<li>
Gross Margin: The company excels with a remarkable gross margin of 33.87%, indicating superior cost efficiency and profitability compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): The company excels with an EPS that surpasses the industry average. With a current EPS of 0.41, Westlake Chemical showcases strong earnings per share.
</li>
</ul>
Debt Management: Westlake Chemical's debt-to-equity ratio stands notably higher than the industry average, reaching 1.43. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
In-Depth Valuation Examination:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current P/E ratio of 14.42 is below industry norms, indicating potential undervaluation and presenting an investment opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: The P/S ratio of 0.66 is lower than the industry average, implying a discounted valuation for Westlake Chemical's stock in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio of 2.38 trails industry averages, indicating a potential disparity in market valuation that could be advantageous for investors.
</li>
</ul>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Impact of Insider Transactions on Investments</h3>
Insightful as they may be, insider transactions should be considered alongside a thorough examination of other investment criteria.
Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.
Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.
But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Deciphering Transaction Codes in Insider Filings</h3>
For <a href="https://www.benzinga.com/money/investing-tools">investors</a>, a primary focus lies on transactions occurring in the open market, as indicated in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001604665">Check Out The Full List Of Westlake Chemical's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Smart Money Move: Andrew Kenner Grabs $111K Worth Of Westlake Chemical Stock

A significant insider buy by Andrew Kenner, SVP at Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>), was executed on March 25, and reported in the recent SEC filing.
What Happened: In a significant move reported in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001604665/000095017024035688//Archives/edgar/data/1604665/000095017024035688/0000950170-24-035688-index.htm">U.S. Securities and Exchange Commission</a> on Monday, Kenner purchased 4,230 shares of Westlake Chemical, demonstrating confidence in the company's growth potential. The total value of the transaction stands at $93,736.
Monitoring the market, Westlake Chemical's shares down by 2.42% at $21.75 during Monday's morning.
<h3>Delving into Westlake Chemical's Background</h3>
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develop ethyelene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
<h3>Understanding the Numbers: Westlake Chemical's Finances</h3>
Revenue Challenges: Westlake Chemical's revenue growth over 3 months faced difficulties. As of 31 December, 2023, the company experienced a decline of approximately -18.96%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Materials sector.
Analyzing Profitability Metrics:
<ul>
<li>
Gross Margin: The company maintains a high gross margin of 33.87%, indicating strong cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Westlake Chemical's EPS is significantly higher than the industry average. The company demonstrates a robust bottom-line performance with a current EPS of 0.41.
</li>
</ul>
Debt Management: Westlake Chemical's debt-to-equity ratio surpasses industry norms, standing at 1.43. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
Valuation Analysis:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 14.47 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 0.66, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Westlake Chemical's EV/EBITDA ratio at 2.39 suggests potential undervaluation, falling below industry averages.
</li>
</ul>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Understanding the Significance of Insider Transactions</h3>
Investors should view insider transactions as part of a multifaceted analysis and not rely solely on them for decision-making.
From a legal standpoint, the term "insider" pertains to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as outlined in Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and significant hedge funds. These insiders are mandated to inform the public of their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
A company insider's new purchase is a indicator of their positive anticipation for a rise in the stock.
While insider sells may not necessarily reflect a bearish view and can be motivated by various factors.
<h3>Important Transaction Codes</h3>
Digging into the details of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their attention to those taking place in the open market, as outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001604665">Check Out The Full List Of Westlake Chemical's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Andrew Kenner's Recent Buy: Acquires $93K In Westlake Chemical Stock

On March 15, 2024, Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) will distribute a dividend payout of $0.20 per share, equating to an annualized dividend yield of 1.56%. Shareholders who owned the stock before the ex-dividend date on March 06, 2024 will receive this payout.
<h3>Olin Recent Dividend Payouts</h3>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style><table>
<thead>
<tr>
<th>Ex-Date</th>
<th style="text-align: right;">Payments per year</th>
<th>Dividend</th>
<th>Yield</th>
<th>Announced</th>
<th>Record</th>
<th>Payable</th>
</tr>
</thead>
<tbody>
<tr>
<td>2024-03-06</td>
<td style="text-align: right;">4</td>
<td>$0.2</td>
<td>1.56%</td>
<td>2024-02-21</td>
<td>2024-03-07</td>
<td>2024-03-15</td>
</tr>
<tr>
<td>2023-11-08</td>
<td style="text-align: right;">4</td>
<td>$0.2</td>
<td>1.78%</td>
<td>2023-10-26</td>
<td>2023-11-09</td>
<td>2023-12-08</td>
</tr>
<tr>
<td>2023-08-09</td>
<td style="text-align: right;">4</td>
<td>$0.2</td>
<td>1.44%</td>
<td>2023-07-27</td>
<td>2023-08-10</td>
<td>2023-09-08</td>
</tr>
<tr>
<td>2023-05-10</td>
<td style="text-align: right;">4</td>
<td>$0.2</td>
<td>1.51%</td>
<td>2023-04-27</td>
<td>2023-05-11</td>
<td>2023-06-09</td>
</tr>
<tr>
<td>2023-03-03</td>
<td style="text-align: right;">4</td>
<td>$0.2</td>
<td>1.32%</td>
<td>2023-02-22</td>
<td>2023-03-06</td>
<td>2023-03-13</td>
</tr>
<tr>
<td>2022-11-09</td>
<td style="text-align: right;">4</td>
<td>$0.2</td>
<td>1.62%</td>
<td>2022-10-26</td>
<td>2022-11-10</td>
<td>2022-12-09</td>
</tr>
<tr>
<td>2022-08-09</td>
<td style="text-align: right;">4</td>
<td>$0.2</td>
<td>1.62%</td>
<td>2022-07-28</td>
<td>2022-08-10</td>
<td>2022-09-09</td>
</tr>
<tr>
<td>2022-05-09</td>
<td style="text-align: right;">4</td>
<td>$0.2</td>
<td>1.54%</td>
<td>2022-04-27</td>
<td>2022-05-10</td>
<td>2022-06-10</td>
</tr>
<tr>
<td>2022-03-03</td>
<td style="text-align: right;">4</td>
<td>$0.2</td>
<td>1.62%</td>
<td>2022-02-23</td>
<td>2022-03-04</td>
<td>2022-03-11</td>
</tr>
<tr>
<td>2021-11-09</td>
<td style="text-align: right;">4</td>
<td>$0.2</td>
<td>1.45%</td>
<td>2021-10-28</td>
<td>2021-11-10</td>
<td>2021-12-10</td>
</tr>
<tr>
<td>2021-08-09</td>
<td style="text-align: right;">4</td>
<td>$0.2</td>
<td>1.81%</td>
<td>2021-07-22</td>
<td>2021-08-10</td>
<td>2021-09-10</td>
</tr>
<tr>
<td>2021-05-07</td>
<td style="text-align: right;">4</td>
<td>$0.2</td>
<td>2.03%</td>
<td>2021-04-21</td>
<td>2021-05-10</td>
<td>2021-06-10</td>
</tr>
</tbody>
</table>
In terms of dividend yield, Olin finds itself in the middle ground among its industry peers, while Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) takes the lead with the highest annualized dividend yield at 8.38%.
<h3>Analyzing Olin Financial Health</h3>
Companies that pay out steady cash dividends are attractive to income-seeking investors, and companies that are financially healthy tend to maintain their dividend payout schedule. For this reason, investors can find it insightful to see if a company has been increasing or decreasing their dividend payout schedule and if their earnings are growing. 
<h3>YoY Growth in Dividend Per Share</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1710515135_0.png" alt="dividend chart graph" />
As you can see, from 2020 to 2023, investors observed a stable dividend per share of $0.80 throughout this period. This indicates a consistent dividend policy maintained by the company, providing stability to shareholders. Investors can rely on the company's consistent dividend payout to generate a steady income stream.
<h3>YoY Earnings Growth For Olin</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1710515135_1.png" alt="earning chart graph" />
From 2020 to 2023, Olin has demonstrated an upward trend in earnings, with earnings per share rising from $-1.10 to $4.54. This positive earnings growth bodes well for investors looking to generate income through cash dividend payouts.
<h3>Recap</h3>
In this article, we delve into Olin's recent dividend payout and examine how it impacts shareholders. The company has announced a dividend distribution of $0.20 per share today, resulting in an annualized dividend yield of 1.56%.
In terms of dividend yield, Olin finds itself in the middle ground among its industry peers, while Westlake Chemical takes the lead with the highest annualized dividend yield at 8.38%.
The unaltered dividend per share during 2020 to 2023 does not diminish the significance of the increasing earnings per share for Olin. This upward trend suggests the company's financial stability and its potential to sustain the distribution of profits to shareholders.
To stay informed about changes in financials or dividend disbursements, investors should pay close attention to the company's performance in the upcoming quarters.
[Click here](<a href="https://www.benzinga.com/stock//dividends" title="https://www.benzinga.com/stock//dividends">https://www.benzinga.com/stock//dividends</a>) to find details on Olin's previous dividends.
To keep track of which companies are distributing dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Dividends

Olin: Reliable Progress and Investor Expectations

On March 08, 2024, Dow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>) will distribute a dividend payout of $0.70 per share, equating to an annualized dividend yield of 5.23%. Shareholders who owned the stock before the ex-dividend date on February 28, 2024 will receive this payout.
<h3>Dow Recent Dividend Payouts</h3>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style><table>
<thead>
<tr>
<th>Ex-Date</th>
<th style="text-align: right;">Payments per year</th>
<th>Dividend</th>
<th>Yield</th>
<th>Announced</th>
<th>Record</th>
<th>Payable</th>
</tr>
</thead>
<tbody>
<tr>
<td>2024-02-28</td>
<td style="text-align: right;">4</td>
<td>$0.7</td>
<td>5.23%</td>
<td>2024-02-15</td>
<td>2024-02-29</td>
<td>2024-03-08</td>
</tr>
<tr>
<td>2023-11-29</td>
<td style="text-align: right;">4</td>
<td>$0.7</td>
<td>5.5%</td>
<td>2023-10-12</td>
<td>2023-11-30</td>
<td>2023-12-08</td>
</tr>
<tr>
<td>2023-08-30</td>
<td style="text-align: right;">4</td>
<td>$0.7</td>
<td>5.09%</td>
<td>2023-08-09</td>
<td>2023-08-31</td>
<td>2023-09-08</td>
</tr>
<tr>
<td>2023-05-30</td>
<td style="text-align: right;">4</td>
<td>$0.7</td>
<td>4.92%</td>
<td>2023-04-13</td>
<td>2023-05-31</td>
<td>2023-06-09</td>
</tr>
<tr>
<td>2023-02-27</td>
<td style="text-align: right;">4</td>
<td>$0.7</td>
<td>4.68%</td>
<td>2023-02-09</td>
<td>2023-02-28</td>
<td>2023-03-10</td>
</tr>
<tr>
<td>2022-11-29</td>
<td style="text-align: right;">4</td>
<td>$0.7</td>
<td>6.39%</td>
<td>2022-10-13</td>
<td>2022-11-30</td>
<td>2022-12-09</td>
</tr>
<tr>
<td>2022-08-30</td>
<td style="text-align: right;">4</td>
<td>$0.7</td>
<td>5.31%</td>
<td>2022-08-10</td>
<td>2022-08-31</td>
<td>2022-09-09</td>
</tr>
<tr>
<td>2022-05-27</td>
<td style="text-align: right;">4</td>
<td>$0.7</td>
<td>4.43%</td>
<td>2022-04-13</td>
<td>2022-05-31</td>
<td>2022-06-10</td>
</tr>
<tr>
<td>2022-02-25</td>
<td style="text-align: right;">4</td>
<td>$0.7</td>
<td>4.52%</td>
<td>2022-02-10</td>
<td>2022-02-28</td>
<td>2022-03-11</td>
</tr>
<tr>
<td>2021-11-29</td>
<td style="text-align: right;">4</td>
<td>$0.7</td>
<td>4.92%</td>
<td>2021-10-14</td>
<td>2021-11-30</td>
<td>2021-12-10</td>
</tr>
<tr>
<td>2021-08-30</td>
<td style="text-align: right;">4</td>
<td>$0.7</td>
<td>4.36%</td>
<td>2021-08-12</td>
<td>2021-08-31</td>
<td>2021-09-10</td>
</tr>
<tr>
<td>2021-05-27</td>
<td style="text-align: right;">4</td>
<td>$0.7</td>
<td>4.36%</td>
<td>2021-04-15</td>
<td>2021-05-28</td>
<td>2021-06-11</td>
</tr>
</tbody>
</table>
With a dividend yield that places it neither at the top nor the bottom, Dow finds itself in the middle among its industry peers, while Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) boasts the highest annualized dividend yield at 8.38%.
<h3>Analyzing Dow Financial Health</h3>
Companies that pay out steady cash dividends are attractive to income-seeking investors, and companies that are financially healthy tend to maintain their dividend payout schedule. For this reason, investors can find it insightful to see if a company has been increasing or decreasing their dividend payout schedule and if their earnings are growing. 
<h3>YoY Growth in Dividend Per Share</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1709910330_0.png" alt="dividend chart graph" />
The company has consistently maintained a dividend per share of $2.80 from 2020 to 2023. This unwavering dividend policy instills confidence in investors, as they can rely on a consistent income stream from the company's dividends.
<h3>YoY Earnings Growth For Dow</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1709910330_1.png" alt="earning chart graph" />
From 2020 to 2023, Dow has demonstrated an upward trend in earnings, with earnings per share rising from $1.61 to $2.27. This positive earnings growth bodes well for investors looking to generate income through cash dividend payouts.
<h3>Recap</h3>
This article delves into the recent dividend payout of Dow and its implications for shareholders. Presently, the company is distributing a dividend of $0.70 per share, leading to an annualized dividend yield of 5.23%.
With a dividend yield that places it neither at the top nor the bottom, Dow finds itself in the middle among its industry peers, while Westlake Chemical boasts the highest annualized dividend yield at 8.38%.
The unaltered dividend per share during 2020 to 2023 does not diminish the significance of the increasing earnings per share for Dow. This upward trend suggests the company's financial stability and its potential to sustain the distribution of profits to shareholders.
It is essential for investors to closely track the company's performance in the coming quarters to remain updated regarding any alterations in financials or dividend disbursements.
[Click here](<a href="https://www.benzinga.com/stock//dividends" title="https://www.benzinga.com/stock//dividends">https://www.benzinga.com/stock//dividends</a>) to find details on Dow's previous dividends.
To keep track of which companies are distributing dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Increasing Performance and Stable Payouts: Dow Benefits Investors with Growing Earnings

Wall Street reopened on a weaker note following Monday&#8217;s market closure, with all major U.S. stock averages in the red due to a broad <a href="https://www.benzinga.com/markets">decline in technology stocks.</a>
As of midday Tuesday, the Nasdaq 100 had fallen by 1.5% after closing 0.9% lower on Friday, marking its worst two-day streak since late January.
Investors are focusing on key market events scheduled for Wednesday, including the release of the latest minutes from the Federal Open Market Committee and Nvidia&#8216;s earnings report after the market closes.
The chipmaker giant&#8217;s shares plummeted by 6% on Tuesday, marking its worst-performing session since late 2022. Its peer Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), experienced an even steeper decline, falling by 6.5%. Among the so-called Magnificent Seven stocks, only Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) managed to avoid losses, posting a modest gain of 0.3%. Tesla tumbled over 5%, potentially marking its worst session since late January.
Tuesday&#8217;s market movements were not driven by concerns over fewer interest rate cuts on the horizon than anticipated. Interest rate expectations in the money markets remained largely unchanged from Friday, with traders pricing in a full percentage point of cuts by December 2024. Treasury yields dropped by about 5 basis points across key maturities and the U.S. dollar remained stable.
Instead, it appears that a reassessment of broader stock valuations is underway, as the forward price-to-earnings ratios for both the S&amp;P 500 and the Nasdaq 100 continues to exceed five-year averages.
<h2 class="wp-block-heading">Tuesday's Performance In Major Indices, ETFs</h2>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>38,486.50</td>
<td>-0.4%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>4,962.37</td>
<td>-0.9%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>17,427.99</td>
<td>-1.5%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>198.56</td>
<td>-1.5%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) was 0.8% lower to $495.31, the SPDR Dow Jones Industrial Average (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) fell 0.3% to $384.93 and the tech-heavy Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) fell 1.4% to $424.60, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>. 
The Technology Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>), was the notable underperformer, down by 1.8%, while the Consumer Staples Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>) was the top gainer, up 1%. 
<h2 class="wp-block-heading">Tuesday&#8217;s Stock Movers</h2>
<ul>
<li>Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) rose over 3% on better-than-expected company results in the last quarter of 2023, hitting fresh all-time highs and the strongest one-day surge since November 2022. The retailer giant also announced plans to acquire smart-TV maker Vizio Holding Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZIO#NYSE">VZIO</a>)</li>
<li>Logistic company Expeditors International of Washington Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXPD#NYSE">EXPD</a>) fell 6.5% after the company missed both revenue and profit forecasts last quarter. </li>
<li>Other companies reacting to earnings were Home Depot Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>), down 0.3%, Westlake Chemical Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>), down 0.8%, CenterPoint Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNP#NYSE">CNP</a>), up 0.3%. </li>
<li>Discover Financial Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DFS#NYSE">DFS</a>) rose by over 14% following the announcement that Capital One Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>) plans to acquire the credit card issuer in an all-stock deal valued at $35.3 billion.</li>
<li>Large-cap companies reporting after the market close on Tuesday are Palo Alto Networks Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>), Public Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSA#NYSE">PSA</a>), Realty Income Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/O#NYSE">O</a>), Costar Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGP#NASDAQ">CSGP</a>), Diamondback Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>) and Keysight Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEYS#NYSE">KEYS</a>) </li>
</ul>
Read now: <a href="https://www.benzinga.com/news/earnings/24/02/37213218/walmart-q4-performance-revenue-and-eps-surprise-dividend-hike-vizio-buyout-and-more">Walmart Q4 Performance: Revenue And EPS Surprise, Dividend Hike, VIZIO Buyout And More</a>
Photo via Shutterstock.

Analyst Color

Equities

Large Cap

Mid Cap

Sector ETFs

Bonds

Broad U.S. Equity ETFs

Asset Sales

Federal Reserve

Analyst Ratings

Tech

ETFs

CSGP

SPDR Dow Jones Industrial Average ETF Trust

EXPD

FANG

GOOGL

KEYS

PANW

VZIO

Wall Street Faces Selling Pressure, Nvidia Investors Pull Back Ahead Of Earnings, Fed Minutes: What's Driving Markets Tuesday?

ABCL

ADEA

ALLE

AMPL

ANDE

AROC

AVNS

AXSM

BTCY

BYON

CAMT

CMTG

CRNT

DBRG

DFIN

ENLC

ENVX

ESRT

ETRN

GATO

GMED

HALO

HCKT

ILPT

INST

JBGS

LAND

LGIH

MATX

MFIN

MIDD

MTDR

MTTR

NXRT

QUAD

SEDG

SEVN

SKWD

SMMT

SPNS

SPNT

TCMD

TDOC

Earnings Scheduled For February 20, 2024

Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) reported its Q4 earnings results on Tuesday, February 20, 2024 at 06:30 AM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Westlake Chemical missed estimated earnings by 8.89%, reporting an EPS of $0.41 versus an estimate of $0.45.
Revenue was down $69.57 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.07 which was followed by a 3.25% drop in the share price the next day.
Here's a look at Westlake Chemical's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.44</td>
<td>0.36</td>
<td>0.47</td>
<td>0.48</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.37</td>
<td>0.34</td>
<td>0.42</td>
<td>0.48</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>357.02M</td>
<td>287.47M</td>
<td>391.10M</td>
<td>397.69M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>321.66M</td>
<td>264.18M</td>
<td>307.68M</td>
<td>366.84M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Westlake Chemical <a href="https://www.benzinga.com/quote/WLKP/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Westlake Chemical: Q4 Earnings Insights

Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) reported quarterly earnings of $0.41 per share which missed the analyst consensus estimate of $0.45 by 8.89 percent. This is a 14.58 percent decrease over earnings of $0.48 per share from the same period last year. The company reported quarterly sales of $297.27 million which missed the analyst consensus estimate of $317.00 million by 6.22 percent. This is a 18.96 percent decrease over sales of $366.84 million the same period last year.

Westlake Chemical Q4 EPS $0.41 Misses $0.45 Estimate, Sales $297.27M Miss $317.00M Estimate

Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) is set to give its latest quarterly earnings report on Tuesday, 2024-02-20. Here's what investors need to know before the announcement.
Analysts estimate that Westlake Chemical will report an earnings per share (EPS) of $0.45. 
Westlake Chemical bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company missed EPS by $0.07, which was followed by a 3.25% drop in the share price the next day.
Here's a look at Westlake Chemical's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.44</td>
<td>0.36</td>
<td>0.47</td>
<td>0.48</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.37</td>
<td>0.34</td>
<td>0.42</td>
<td>0.48</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-3.25%</td>
<td>-0.48%</td>
<td>2.41%</td>
<td>-0.98%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1708362093_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Westlake Chemical were trading at $22.25 as of February 15. Over the last 52-week period, shares are down 5.06%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/WLKP/earnings">To track all earnings releases for Westlake Chemical visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Westlake Chemical Earnings Preview

In a report released today, Michael Leithead from Barclays maintained a Buy rating on Westlake Chemical PRN (WLKP – Research Report), with a price ...

Westlake Chemical PRN (WLKP) Receives a Buy from Barclays

METCB May Be Yielding Over 12% In 2025 At A Sub $10 Stock Price

Westlake Chemical Partners declares $0.4714 dividend

Westlake Chemical Partners: A Value Investor's Dream With Superb Dividend

Here's the major earnings before the open tomorrow

Westlake Chemical Partners reports Q3 results

Westlake Chemical PRN ( ($WLKP) ) just unveiled an update. Westlake Chemical Partners LP has reported a strong third quarter for 2024, marking a ne...

Westlake Chemical PRN Reports Strong Q3 2024 Earnings

Westlake Chemical Partners LP Common Units 2024 Q3 - Results - Earnings Call Presentation

Westlake Chemical Partners LP Common Units (WLKP) Q3 2024 Earnings Call Transcript

Westlake Chemical Partners LP ( ($WLKP) ) has released its Q3 earnings. Here is a breakdown of the information Westlake Chemical Partners LP presen...

Westlake Chemical Partners LP Reports Strong Q3 2024 Results

ACDC

AGCO

APLS

ARCH

BEAM

BLDP

BLDR

BRKR

CEIX

CNSL

DHLGY

DNNGY

ENDPQ

GLDD

GOGO

HSIC

INGR

KPTI

METC

METCB

MITT

MLCO

MPLX

NMRK

ONIT

OXSQ

PAYO

PMTS

PTLO

RACE

SHIP

SNDL

SQNS

TCNNF

TRGP

USAC

VWDRY

Press Releases

Westlake Chemical Partners LP Announces First Quarter 2024 Results

Westlake Chemical Partners Provides Tax Reporting Information

Westlake Implements Succession Plan

Westlake Chemical Partners Implements Succession Plan

Westlake Chemical Partners Announce Second Quarter 2024 Earnings Conference Call

Comments

Westlake Chemical

Westlake Chemical (WLKP) Opzioni

Westlake Chemical (NYSE:WLKP) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO